DESIGN-ZYME LLC
DESIGN-ZYME LLC is a federal contractor, registered under UEI RM33XDX5RRG4 and CAGE code 7KSG8. It has been awarded $4,778,819 in federal contracts. Primary work spans Research and Development in Biotechnology (except Nanobiotechnology), Unknown NAICS, and Research and Development in Biotechnology. Top awarding agencies include Department Of Health And Human Services and Department Of Defense.
Contact Information
Registration and classification details
Registration
UEI Code
RM33XDX5RRG4CAGE Code
7KSG8Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
DESIGN-ZYME LLC specializes in the design and development of novel biotechnological adjuvants for next-generation vaccine platforms, with a focused expertise in covalent chemistry applied to polysaccharide-based immunomodulators. Their technical capabilities center on the synthesis and characterizat...
DESIGN-ZYME LLC specializes in the design and development of novel biotechnological adjuvants for next-generation vaccine platforms, with a focused expertise in covalent chemistry applied to polysaccharide-based immunomodulators. Their technical capabilities center on the synthesis and characterization of chemically modified hyaluronic acid derivatives optimized for enhanced antigen presentation and dendritic cell activation, positioning them at the intersection of glycoconjugate chemistry and mucosal immunology. The company applies precise bioconjugation techniques to engineer stable, multivalent vaccine formulations capable of eliciting robust T-cell and humoral responses against complex pathogens like Borrelia burgdorferi, demonstrating deep proficiency in antigen-adjuvant co-formulation, stability profiling, and preclinical immunogenicity assessment. Their differentiation lies in leveraging covalent bonding strategies to overcome the limitations of traditional alum or oil-in-water adjuvants, enabling more targeted and durable immune priming without excessive reactogenicity. The contractor has delivered research and development services exclusively to the Department of Health and Human Services, specifically supporting advanced vaccine development initiatives under public health preparedness mandates. Their engagement reflects a mission-aligned partnership focused on addressing emerging infectious disease threats through innovative immunological engineering. Their primary industry focus is Research and Development in Biotechnology (NAICS 541714), where they operate within the niche of non-nanoparticle-based biologic adjuvants, serving the federal vaccine development ecosystem. This specialization aligns with HHS priorities in Lyme disease prevention and next-generation multivalent vaccine platforms, distinguishing them from broader biotech firms by their chemical precision and focus on carbohydrate-based immunomodulation. DESIGN-ZYME LLC is a small, privately held entity based in Lawrence, Kansas, with no federal certifications on record. Operating as a lean R&D firm, they maintain a focused geographic footprint centered on Kansas but serve national public health objectives through targeted federal contracts. Their market positioning is that of a specialized biotechnology innovator advancing novel adjuvant technologies for federal vaccine programs.
Key Performance Metrics
Awards Count
6
All time
Active
1
Currently performing
Completed
5
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with DESIGN-ZYME LLC
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for DESIGN-ZYME LLC
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
